» Articles » PMID: 23084872

MiRNA, Development and Disease

Overview
Journal Adv Genet
Specialty Genetics
Date 2012 Oct 23
PMID 23084872
Citations 37
Authors
Affiliations
Soon will be listed here.
Citing Articles

Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case report.

Kimura T, Sakata K, Ohga N, Sato J, Itagaki T, Munekata T Oncol Lett. 2024; 29(1):52.

PMID: 39564374 PMC: 11574702. DOI: 10.3892/ol.2024.14798.


A method for miRNA diffusion association prediction using machine learning decoding of multi-level heterogeneous graph Transformer encoded representations.

Wen S, Liu Y, Yang G, Chen W, Wu H, Zhu X Sci Rep. 2024; 14(1):20490.

PMID: 39227405 PMC: 11371806. DOI: 10.1038/s41598-024-68897-4.


Advances and Obstacles in Using CRISPR/Cas9 Technology for Non-Coding RNA Gene Knockout in Human Mesenchymal Stromal Cells.

Basalova N, Illarionova M, Skryabina M, Vigovskiy M, Tolstoluzhinskaya A, Primak A Noncoding RNA. 2023; 9(5).

PMID: 37736895 PMC: 10514828. DOI: 10.3390/ncrna9050049.


The role of viruses in cancer development versus cancer therapy: An oncological perspective.

Javid H, Sharbaf Mashhad A, Yazdani S, Akbari Oryani M, Akbari S, Rezagholinejad N Cancer Med. 2023; 12(10):11127-11148.

PMID: 36880311 PMC: 10242333. DOI: 10.1002/cam4.5694.


Prognostic Nomogram of Prognosis-Related Genes and Clinicopathological Characteristics to Predict the 5-Year Survival Rate of Colon Cancer Patients.

Huang C, Zhao J, Zhu Z Front Surg. 2021; 8:681721.

PMID: 34222322 PMC: 8242155. DOI: 10.3389/fsurg.2021.681721.